A Phase 1 Study of CDX-0159
Completed · Phase 1
Conditions studied: Healthy Subjects
In brief
This is a study to determine the safety of CDX-0159 in healthy subjects.
Key facts
- Study ID
- NCT04146129
- Run by
- Celldex Therapeutics
- People needed
- 32
- Starts
- 2019-10-29
- Expected to finish
- 2020-06-26
- Last updated by the study team
- 2020-07-07
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Altasciences Clinical Kansas, Inc. — Overland Park, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.